Rx Medical Food to Make Strong Progress

Medical food is a category of products for dietary management or supportive therapy for specific disease or medical conditions such as pulmonary and metabolic disorders. Ingredients used in medical foods must have generally recognized as safe (GRAS) status, which is assigned to naturally found food materials. Medical food is different from nutritional food, dietary supplements, and prescription drugs. Medical food is protein-based, nutrient-based (Omega 3 fatty acids, chelated zinc, and isoflavones), and may contain minerals and vitamins such as folic acid and thiamine. These products are prescribed by physicians or taken under their supervision. The U.S. Food & Drug Administration (FDA) has classified medical foods into four major categories namely, nutritional complete products, nutritionally incomplete products, formulas for metabolic disorders, and oral rehydration solutions. The U.S. FDA separately regulates medical food category under Orphan Drug Act (1988) to ensure safety of populace and curb presence of products falsely claiming to cure medical conditions. Medical food does not require premarket approval, specification as an Investigational New Drug (IND), and individual registration with the FDA. However, they are required to support all their health claims with proper laboratory and clinical studies.

To get holistic SAMPLE of the report, please click: https://www.coherentmarketinsights.com/insight/request-sample/909

Increasing regulatory support and awareness about medical food among healthcare professionals is expected to fuel market growth

The U.S. FDA amended regulations related to formulation and marketing of medical food in 2013, the category, which was previously ill-defined. The new additions clarified some issues associated with marketing and branding of medical food products. Furthermore, the U.S. FDA also states that medical food does not require prescription, rather requires to be consumed under the supervision of a medical practitioner. Furthermore, the medical food market is expected to gain traction, owing to major investments by players such as Nestlé and Danone in research and development of medical foods along with widening scope of applications such as chronic pain, and personalized medicine. Medical food currently available in the market include Axona (Accera), Limbrel, Deplin, Lofenalac, Ensure, Vasculera, and Vascazen.

The global Rx medical food market was valued at US$ 14,504.6 million in 2016 and is expected to witness a robust CAGR of 7.0% over the forecast period (2017-2025).

North America is expected to hold a dominant position in the Rx medical food market over the forecast period, followed by Europe and Asia-Pacific

North America accounts for the largest share in the Rx medical food market, followed by Europe and Asia-pacific. The regulatory authorities in North America and Europe have clearly defined and distinguished the medical food category. Furthermore, medical food is also being regulated in Australia and New Zealand, under Food Standards Code 2.9.5. Asia-Pacific region holds major untapped market potential with strengthening regulations in the region. The Council for Responsible Nutrition (CRN), U.S., the leading trade association for the dietary supplement and functional food industry, announced to explore and include medical food as part of its mission, in 2017. The CRN will provide a common platform for major players in the industry to work together towards the advancement of medical food and to increase awareness about medical food among healthcare practitioners and consumers. Nestlé has set out a US$ 500 Mn budget to support medical food research by 2021, which is expected to boost growth of the Rx medical food market over the forecast period.

Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/909

Some major players operating in the Rx medical food market are Abbott Laboratories, Danone, Mead Johnson & Company, LLC, Fresenius Kabi AG, Nestle, Primus Pharmaceuticals, Inc., Targeted Medical Pharma, Enzymotec ltd., AlfaSigma, and Pivotal Therapeutics.

You may be interested

Business

UC Headsets Market Future Demand Analysis, Industry Sizes, Market Share And Market Overview 2018 – 2023

Albert R - December 13, 2018

UC Headsets Market is anticipated to have maximum growth during years 2018 to 2023 according to the latest research made by WMR. This UC Headsets Market Intelligence…

Business

North America Locker Locks Market 2018-2023 Key Players, Industry Value Chain Structure And Demand Analysis

Albert R - December 13, 2018

North America Locker Locks Market is anticipated to have maximum growth during years 2018 to 2023 according to the latest research made by WMR. This North America…

Business

Testing, Inspection Certification Market 2018 To 2023 Future Growth Analysis, Industry Sizes, Market Overviews

Albert R - December 13, 2018

Testing, Inspection Certification Market is anticipated to have maximum growth during years 2018 to 2023 according to the latest research made by WMR. This Testing, Inspection Certification…

Most from this category